Log in to save to my catalogue

Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia

Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_492268

Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia

About this item

Full title

Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia

Journal title

The Lancet (British edition), 2017-11, Vol.390 (10110), p.2343

Language

English

Formats

More information

Alternative Titles

Full title

Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_492268

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_492268

Other Identifiers

ISSN

0140-6736

DOI

10.1016/S0140-6736(17)32894-5

How to access this item